Navigation Links
ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
Date:7/2/2009

LEUVEN, Belgium and LUND, Sweden, July 3 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402. This follows completion of recruitment of the first cohort of 100 patients ahead of schedule. TB-402 is a novel, long acting anticoagulant that is being developed for the prevention of deep vein thrombosis (DVT) following orthopaedic surgery. The decision to move ahead with the second cohort of this trial follows unanimous advice from the external efficacy and safety monitoring board to proceed using a higher dose of TB-402.

The Phase II trial is an active (enoxaparin)-controlled, dose-escalating, multicenter, prospective, randomised, open label trial evaluating TB-402 for the prophylaxis of DVT after knee surgery. The study is assessing three different doses of TB-402 given as a single intravenous bolus injection post knee replacement surgery, and will enrol a total of 300 patients across 36 centers, mainly in Europe. The objective of the study is to assess the safety and efficacy of the three escalating doses of TB-402.

TB-402 is a recombinant human monoclonal antibody that partially inhibits Factor VIII, a key component of the coagulation cascade. This novel mode of action is expected to reduce the risk of undesirable bleeding events, even at high doses, as well as the need for patient monitoring. These are the two main drawbacks associated with current anticoagulants. In addition, TB-402 is a long-acting agent, which means it could be given as a single dose after surgery to prevent the development of DVT. This would be an attractive option, as all current anticoagulant treatment options require daily treatment for up to several weeks.

Professor Peter Verhamme from the University of Leuven will present additi
'/>"/>

SOURCE ThromboGenics NV and BioInvent International
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
4. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
5. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
6. ThromboGenics Microplasmin Phase III Program Progressing According to Schedule
7. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
8. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
9. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
10. InterMune Announces Start of Phase 1b Trial of ITMN-191
11. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... WARSAW, Ind. , May 28, 2015 ... today that it has finalized agreements with buyers to ... certain Zimmer® Unicompartmental High-Flex Knee System assets, Biomet Discovery® ... divestiture agreements are in furtherance of Zimmer,s pending acquisition ... Zimmer continues to work constructively with the ...
(Date:5/28/2015)... -- Maetrics ( http://maetrics.com ), a leading international consulting firm ... successful conference, "The cost of non-compliance -- How new regulation ... Zurich . Hosted by ... Switzerland -based team, experts provided insights on the ... an exclusive local audience. The event was held in ...
(Date:5/28/2015)... May 28, 2015 The controversy surrounding ... hysterectomies and myomectomies (procedures to remove uterine fibroids) ... FBI is investigating Johnson & Johnson,s Ethicon, Inc. ... the devices. According to the report published by ... , the FBI is trying to determine what ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
... Codexis, Inc. today announced that Fernando Valle, Ph.D., has ... Valle, a distinguished researcher in metabolic and genetic engineering ... focus on Codexis, advanced biofuels programs. He will report ... , Dr. Valle joins Codexis from LS9, where ...
... CVS Caremark (NYSE: CVS ) today announced the ... Marketing for its pharmacy benefit management business. Greer ... Bruner, who is transitioning to the new role of ... ) , Greer brings twenty years of ...
Cached Medicine Technology:Codexis Names Fernando Valle Research Fellow 2Company Appoints New SVP, Marketing for PBM Business 2
(Date:5/29/2015)... 29, 2015 The Recovery Village ... abuse, and co-occurring mental health treatment facility, will ... for the general public on June 1st, and ... Recovery Village at Palmer Lake will offer affordable ... utilizing traditional and evidence-based therapies, in a luxurious ...
(Date:5/29/2015)... 29, 2015 On May 21, 2015, Elle ... When You Get Botox ?” reported on the four ... Elle partnered with Google to determine these results and then ... question in California, for example, is how to keep ... search query is what's the appropriate age to start receiving ...
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... recently partnered with Stratus Video Interpreting ... will facilitate better communication and timely care ... and hearing loss. Stratus’ video remote interpreting ... translators, enabling staff to quickly access qualified ...
(Date:5/29/2015)... Mediaplanet has joined forces with Colorescience to ... Health is a cross-platform campaign with a national reach. ... York, Los Angeles, and Chicago, the campaign is expected ... will reach a national audience through one of Mediaplanet’s ... Health campaign and Colorescience, click here . ...
Breaking Medicine News(10 mins):Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2
... critical to advancing ... eHealth initiatives, ... leader in eHealth technology solutions, announced today its,membership with the ... and public sector organizations,focused on improving health by promoting the ...
... (NQF) announced today that Baylor Health Care System ... Quality Healthcare Award. The award,recognizes exemplary healthcare organizations ... improvement in healthcare, and is,presented in partnership with ... National Quality Healthcare Award will be presented to ...
... New vertical search site for the pharmaceutical ... Convera Corporation,(Nasdaq: CNVR ), http://www.convera.com, ... for publishers, today announced the launch of,PharmaLiveSearch.com, ... pharmaceutical,industry. PharmaLiveSearch.com was developed in partnership with ...
... Joins Board of Directors as Chairman, NASHVILLE, ... today that General Atlantic LLC (General,Atlantic) and affiliates ... all remaining interests in Emdeon held by HLTH ... in Emdeon from HLTH in,November 2006., Emdeon ...
... FOR IMMEDIATE RELEASE , Recordable proteins ... Move over, compact discs, DVDs, and hard drives. Researchers ... memory device that could provide an alternative to conventional ... their memory storage capacities. Their study is scheduled for ...
... Md., Feb. 11 Dialysis Corporation,of America (Nasdaq: ... of its,new dialysis facility in Delaware County, Ohio ... President & CEO Stephen Everett commented, "Our ... passing all required inspections, with zero,deficiencies. The facility ...
Cached Medicine News:Health News:InterComponentWare Inc. Aligns with the Center for Health Transformation 2Health News:InterComponentWare Inc. Aligns with the Center for Health Transformation 3Health News:InterComponentWare Inc. Aligns with the Center for Health Transformation 4Health News:National Quality Forum Names Baylor Health Care System Winner of 2008 NQF National Quality Healthcare Award 2Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 2Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 2Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 9Health News:Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio 2
... aluminum cuffs that can be bent to ... joint alignment, unique slot/screw adjustment mechanism allows ... cuff position. Cuffs are configured to offer ... with contractures.,The hinge can be locked in ...
... Elbow Wrap replaces messy taping and bulky ... others experiencing epicondylitis. Preferred by doctors and ... fit. Two overlay straps allow you to ... lining holds the Elbow Wrap comfortably in ...
... The Bledsoe Original Arm Brace is ... elbow strains and ligament trauma. The Bledsoe ... limited R.O.M. or locked control of the ... Bledsoe Extender Arm Brace can be formed, ...
... lightweight brace allows it to fit easily into ... joint following severe sprains, tendonitis or after cast ... with the ankle and provide optimum medial-lateral support. ... rotational strains on the ankle, and they provide ...
Medicine Products: